➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

Patent: 8,288,396

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,288,396
Title:Pyrimidopyrimidoindazole derivative
Abstract: The invention is to provide a novel anticancer agent or sensitizer for cancer chemotherapy or radiotherapy. A compound of a general formula (I): wherein A means an aryl group or a heteroaryl group, or a group of a formula (a): R.sup.1 means a --(C.dbd.O).sub.aO.sub.b(C1-C6)alkyl group, a --(C.dbd.O).sub.aO.sub.b(C2-C6)alkenyl group, a --(C.dbd.O).sub.aO.sub.b(C3-C6)cycloalkyl group, an aryl group or a heteroaryl group; R.sup.2 and R.sup.3 each mean a hydrogen atom, a halogen atom, a hydroxyl group, a carboxyl group, a --(C.dbd.O).sub.aO.sub.b(C1-C6)alkyl group or a group of --(C.dbd.O).sub.aN(R.sup.1e)R.sup.2e; R.sup.4 means a hydrogen atom or a (C1-C6)alkyl group, and the like have an excellent Wee1-kinase-inhibitory effect, and are therefore useful in the field of medicine, especially in the field of various cancer treatments. ##STR00001##
Inventor(s): Goto; Yasuhiro (Tachikawa, JP), Niiyama; Kenji (Tsuchiura, JP), Sunami; Satoshi (Toride, JP), Takahashi; Keiji (Yachiyo, JP)
Assignee: MSDKK (Tokyo, JP)
Application Number:13/202,773
Patent Claims:see list of patent claims

Details for Patent 8,288,396

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genzyme THYROGEN thyrotropin alfa INJECTABLE;INJECTION 020898 001 1999-09-03   Start Trial MSDKK (Tokyo, JP) 2029-02-25 RX search
Genzyme Corporation THYROGEN thyrotropin alfa INJECTION, POWDER, FOR SOLUTION 020898 1 1998-11-30   Start Trial MSDKK (Tokyo, JP) 2029-02-25 search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial MSDKK (Tokyo, JP) 2029-02-25 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.